Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension

In total, 62patients with mild to moderate arterial hypertension underwent echocardiography and Doppler cardiography. For 12 weeks, all participants received spirapril, 6 mg/d. Spirapril therapy was associated with reduced left ventricular hypertrophy and pathological heart remodeling type number.

Bibliographic Details
Main Authors: M. M. Beraya, V. V. Petriy, V. I. Buvaltsev, N. G. Sergushkina, V. I. Makolkin
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2007-02-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2031
id doaj-8acd6a1d39b04b13b39853fa2525c06c
record_format Article
spelling doaj-8acd6a1d39b04b13b39853fa2525c06c2021-07-28T14:02:09Zrus«FIRMA «SILICEA» LLC Российский кардиологический журнал1560-40712618-76202007-02-010145471786Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertensionM. M. Beraya0V. V. Petriy1V. I. Buvaltsev2N. G. Sergushkina3V. I. Makolkin4Московская медицинская академия им. И. М. СеченоваМосковская медицинская академия им. И. М. СеченоваМосковская медицинская академия им. И. М. СеченоваМосковская медицинская академия им. И. М. СеченоваМосковская медицинская академия им. И. М. СеченоваIn total, 62patients with mild to moderate arterial hypertension underwent echocardiography and Doppler cardiography. For 12 weeks, all participants received spirapril, 6 mg/d. Spirapril therapy was associated with reduced left ventricular hypertrophy and pathological heart remodeling type number.https://russjcardiol.elpub.ru/jour/article/view/2031arterial hypertensionremodelingleft ventricular hypertrophyspirapril
collection DOAJ
language Russian
format Article
sources DOAJ
author M. M. Beraya
V. V. Petriy
V. I. Buvaltsev
N. G. Sergushkina
V. I. Makolkin
spellingShingle M. M. Beraya
V. V. Petriy
V. I. Buvaltsev
N. G. Sergushkina
V. I. Makolkin
Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
Российский кардиологический журнал
arterial hypertension
remodeling
left ventricular hypertrophy
spirapril
author_facet M. M. Beraya
V. V. Petriy
V. I. Buvaltsev
N. G. Sergushkina
V. I. Makolkin
author_sort M. M. Beraya
title Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
title_short Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
title_full Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
title_fullStr Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
title_full_unstemmed Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
title_sort spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
publisher «FIRMA «SILICEA» LLC 
series Российский кардиологический журнал
issn 1560-4071
2618-7620
publishDate 2007-02-01
description In total, 62patients with mild to moderate arterial hypertension underwent echocardiography and Doppler cardiography. For 12 weeks, all participants received spirapril, 6 mg/d. Spirapril therapy was associated with reduced left ventricular hypertrophy and pathological heart remodeling type number.
topic arterial hypertension
remodeling
left ventricular hypertrophy
spirapril
url https://russjcardiol.elpub.ru/jour/article/view/2031
work_keys_str_mv AT mmberaya spiraprileffectsonheartremodelinginpatientswithmildtomoderatearterialhypertension
AT vvpetriy spiraprileffectsonheartremodelinginpatientswithmildtomoderatearterialhypertension
AT vibuvaltsev spiraprileffectsonheartremodelinginpatientswithmildtomoderatearterialhypertension
AT ngsergushkina spiraprileffectsonheartremodelinginpatientswithmildtomoderatearterialhypertension
AT vimakolkin spiraprileffectsonheartremodelinginpatientswithmildtomoderatearterialhypertension
_version_ 1721269669337235456